Fondaparinux

• Catalog No.: Fondaparinux
• CAS Number: 114870-03-0
• M. F.: C31H43N3Na10O49S8
• M. W.: 1728.08152

SYNONYMS

• IUPAC name: decasodium (2S,3S,4R,5R,6R)-6-{[(2R,3R,4R,5R,6R)-6-{[(2R,3S,4S,5R,6R)-2-carboxylato-4-hydroxy-6-{[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfonatoamino)-2-[(sulfonatooxy)methyl]oxan-3-yl]oxy}-5-(sulfonatooxy)oxan-3-yl]oxy}-5-(sulfonatoamino)-4-(sulfonatooxy)-2-[(sulfonatooxy)methyl]oxan-3-yl]oxy}-3-{[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfonatoamino)-6-[(sulfonatooxy)methyl]oxan-2-yl]oxy}-4,5-dihydroxyoxane-2-carboxylate
• IUPAC Traditional name: decasodium (2S,3S,4R,5R,6R)-6-{[(2R,3R,4R,5R,6R)-6-{[(2R,3S,4S,5R,6R)-2-carboxylato-4-hydroxy-6-{[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfonatoamino)-2-[(sulfonatooxy)methyl]oxan-3-yl]oxy}-5-(sulfonatooxy)oxan-3-yl]oxy}-5-(sulfonatoamino)-4-(sulfonatooxy)-2-[(sulfonatooxy)methyl]oxan-3-yl]oxy}-3-{[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfonatoamino)-6-[(sulfonatooxy)methyl]oxan-2-yl]oxy}-4,5-dihydroxyoxane-2-carboxylate
• Brand Name: Arixtra

DATABASE IDS

• CHEMBL: 1201202
• Wikipedia Title: Fondaparinux
• Unique Ingredient Identifier: J177FOW5JL
• ATC CODE: B01AX05
• PubChem CID: 636380
• DrugBank ID: DB00569
• Chemspider ID: 552174
• CAS Number: 114870-03-0

PROPERTIES

• Admin Routes: subcutaneous
• Bioavailability: N/A
• Half Life: 17-21 hours
• Legal Status: POM (UK)
• Legal Status: Rx-only (US)
• EU Licence: Arixtra
• US Licence: Fondaparinux
• Metabolism: renally excreted unchanged
• Protein Bound: 94%